Rohan R Chodankar

No ORCID on file · 4 papers in corpus
rct 2023
Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial
EClinicalMedicine ·doi:10.1016/j.eclinm.2023.101995

BACKGROUND: Heavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids. We compared the effectiveness of ulipristal acetate …

review 2022
Historical Perspectives and Evolution of Menstrual Terminology
Frontiers in reproductive health ·doi:10.3389/frph.2022.820029

Abnormal uterine bleeding (AUB) in the reproductive years in non-pregnant women comprises a group of symptoms that include abnormal frequency and the irregular onset of flow as well as prolonged and heavy menstrual bleeding. It is a common,…

review 2022
Uterine bleeding: how understanding endometrial physiology underpins menstrual health
Nature reviews. Endocrinology ·doi:10.1038/s41574-021-00629-4

Menstruation is a physiological process that is typically uncomplicated. However, up to one third of women globally will be affected by abnormal uterine bleeding (AUB) at some point in their reproductive years. Menstruation (that is, endome…

other 2021
The endometrial response to modulation of ligand-progesterone receptor pathways is reversible
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.02.008

OBJECTIVE: To study the impact of the progesterone receptor modulator (PRM), ulipristal acetate (UPA), on endometrial morphology and function. DESIGN: Cross-sectional. SETTING: University Research Institute. PATIENT(S): Endometrial biops…